Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. latamerica
  4. artificial intelligence software
Show results for
Products
Services
Software

Companies

News
Books
Downloads
Videos

Refine by
Date

  • Older

Artificial Intelligence Software Articles & Analysis

33 news found

Caresyntax Announces Launch of Novel Real World Evidence (RWE) Program and Software Portfolio of Digital Catalysts for Commercial Acceleration of Medtech Partners

Caresyntax Announces Launch of Novel Real World Evidence (RWE) Program and Software Portfolio of Digital Catalysts for Commercial Acceleration of Medtech Partners

Caresyntax, the leading vendor-neutral surgical data and intelligence platform converging AI-powered software, devices, and clinical services, today announced the launch of Caresyntax Clinical Data as a Service (CDaaS) for Medtech industry partners. ...

ByCaresyntax


Caresyntax Announces Strategic Collaboration with AAICO to Expand AI-based Solutions In Healthcare

Caresyntax Announces Strategic Collaboration with AAICO to Expand AI-based Solutions In Healthcare

Caresyntax has entered into a strategic collaboration with The Applied AI Company (AAICO), a leading AI technology company, to distribute novel software and artificial intelligence solutions throughout the UAE, US, and Europe. ...

ByCaresyntax


Caresyntax and Sheba ARC Sign Agreement to Develop the Future Model for Surgical Innovation

Caresyntax and Sheba ARC Sign Agreement to Develop the Future Model for Surgical Innovation

Caresyntax, the leading vendor-neutral enterprise surgical data and intelligence platform designed to make surgery smarter and safer by converging AI-powered software, devices, and clinical services, today announced a partnership with ARC (Accelerate, Redesign, Collaborate) Sheba’s Global Innovation platform to establish and replicate the ARC Surgical ...

ByCaresyntax


Optibrium and Lhasa Limited advance predictive modelling for drug-metabolising enzymes

Optibrium and Lhasa Limited advance predictive modelling for drug-metabolising enzymes

Study demonstrates novel predictive models for drug metabolism to improve drug design and Optibrium and Lhasa Limited, two of the leading developers of software and artificial intelligence (AI) solutions for drug discovery and development, today announced the publication of a peer-reviewed study in the Journal of Medicinal Chemistry. ...

ByOptibrium Ltd.


Optibrium expands operations in North America for AI and computational drug discovery technologies

Optibrium expands operations in North America for AI and computational drug discovery technologies

Optibrium, a leading developer of software and artificial intelligence (AI) solutions for drug discovery, today announced the opening of its US subsidiary, Optibrium Inc., and the promotion of Dr Tamsin Mansley to President of the new subsidiary to lead its US-based team and business operations. ...

ByOptibrium Ltd.


Optibrium strengthens global AI drug discovery software operations with three key appointments

Optibrium strengthens global AI drug discovery software operations with three key appointments

Optibrium, a leading developer of software and artificial intelligence (AI) solutions for drug discovery, today announced three key appointments: Michelle Harrison as Head of Strategic Marketing, Chris Khoury as Associate Director of Business Development, and Imran Ghauri as Business Development Manager. ...

ByOptibrium Ltd.


ScreenPoint Medical`s Transpara AI reads over three million mammograms

ScreenPoint Medical`s Transpara AI reads over three million mammograms

Transpara, the world's leading artificial intelligence (AI) breast care software, has now reached a major new milestone, helping radiologists read over three million mammograms. ...

ByScreenPoint Medical


Major clinical study shows Virusight’s SpectraLIT instantly detects COVID-19 with 96.3% accuracy

Major clinical study shows Virusight’s SpectraLIT instantly detects COVID-19 with 96.3% accuracy

Virusight Diagnostic, a world leader in combining artificial intelligence software and spectral technology today announced the results of a major clinical study that found its ultra-rapid, point of care Pathogens Diagnostic solution consistently delivers 96.3% accuracy when compared to the gold standard RT-PCR. ...

ByVirusight


First Patent Regarding RPIDD Infectious Disease Liquid Biopsy Technology DNA Library Preparation and Amplification Methods Granted

First Patent Regarding RPIDD Infectious Disease Liquid Biopsy Technology DNA Library Preparation and Amplification Methods Granted

Proprietary technologies are being developed to enrich pathogenic DNA / RNA for analysis through harnessing the power of Next-Generation Sequencing platforms and proprietary artificial intelligence-based software analytics with the goal to rapidly identify and detect any foreign pathogens (virus, bacteria, fungus, parasites) without bias through ...

ByAptorum Group Limited


Subtle Medical Awarded Federal SBIR Grant for Safer Fluoroscopy Exams

Subtle Medical Awarded Federal SBIR Grant for Safer Fluoroscopy Exams

Subtle Medical was awarded an NIH SBIR grant to develop an innovative artificial intelligence (AI)-powered software, SubtleIR™, which uses deep learning (DL) to reduce radiation dosage needed during fluoroscopy exams. The development of the new software is aligned with the company’s mission to accelerate access to ...

BySubtle Medical, Inc.


First U.S. patients with persistent cardiac arrythmias treated using Volta Medical’s artificial intelligence-based analysis

First U.S. patients with persistent cardiac arrythmias treated using Volta Medical’s artificial intelligence-based analysis

Volta Medical, a pioneering health tech company developing artificial intelligence (AI)-based software solutions to treat cardiac arrythmias, today announced the introduction of its leading-edge product, VX1, at three leading U.S. hospitals. ...

ByVolta Medical


QView Medical maintains leadership position in AI-powered breast cancer screening technology through alliance with GE Healthcare

QView Medical maintains leadership position in AI-powered breast cancer screening technology through alliance with GE Healthcare

QView Medical, a breast cancer detection pioneer and maker of the FDA-approved artificial intelligence (AI) software system for breast cancer screening, and GE Healthcare today announced that QView's QVCAD software can be launched on GE Healthcare's Invenia™ ABUS 2.0 (Automated Breast Ultrasound), which has an open platform ...

ByQView Medical


Qynapse Unveils its New Brand and Latest Developments in Neuroimaging AI Innovation at the 2021 RSNA Meeting in Chicago

Qynapse Unveils its New Brand and Latest Developments in Neuroimaging AI Innovation at the 2021 RSNA Meeting in Chicago

BOSTON, MA, November 22, 2021, PRNewswire – Qynapse Inc., a medical technology company commercializing an artificial intelligence (AI)-powered neuroimaging software platform for central nervous system (CNS) disorders, will unveil its new brand and latest AI developments as a key exhibitor in the AI Showcase at the 107th Radiology ...

ByQynapse


NeuroNav Partners with Axial3D to improve neuronavigation using artificial intelligence

NeuroNav Partners with Axial3D to improve neuronavigation using artificial intelligence

Axial3D is delighted to be working in partnership with NeuroNav to improve the neurosurgical navigation workflow using artificial intelligence (AI). Neurosurgery procedures are extremely complex requiring high precision to avoid damage to vital structures of the brain. ...

ByAxial3D


Data Driven: Immunai Adds Biocuration, European Hubs with Nebion Acquisition

Data Driven: Immunai Adds Biocuration, European Hubs with Nebion Acquisition

AMICA is a downloadable database of annotated multi-omic immune cells that includes information about gene expression, proteins, T-cell and B-cell receptors for immune cells, clinical and/or lab data, and a downloadable artificial intelligence software platform designed for characterizing and analyzing immune cells, as well as analyzing the ...

ByImmunai


AVRA Medical Robotics’ Chief Medical Officer to Reveal Company’s Latest Developments in Surgical Robots at Global Conference

AVRA Medical Robotics’ Chief Medical Officer to Reveal Company’s Latest Developments in Surgical Robots at Global Conference

Taghizadeh is currently working with the Avra engineering group in the design and development of one of the world’s most sophisticated and versatile digital surgery platforms and will update the industry on the progress being made using a combination of imaging, guidance, targeting and intelligence to assist surgeons performing aesthetics and other skin resurfacing ...

BySS Innovations International Inc.


The Ultimate List of Attractive MedTech M&A Targets

The Ultimate List of Attractive MedTech M&A Targets

The company’s main focus is to provide clinical validation for the NUsurface Meniscus Implant, an “artificial meniscus” designed to replace one that is damaged or deteriorating. ...

ByAnuncia Medical, Inc.


Studies suggest Elucid’s AI software helps to objectively quantify key drivers of stroke and heart attack from computed tomography angiography (CTA)

Studies suggest Elucid’s AI software helps to objectively quantify key drivers of stroke and heart attack from computed tomography angiography (CTA)

The question is, how to actualize that benefit and get the most our of the modality. Elucid has developed an artificial intelligence software that might just answer that question. ...

ByElucid


VUNO Med-DeepECG Designated as Breakthrough Device

VUNO Med-DeepECG Designated as Breakthrough Device

South Korean artificial intelligence (AI) developer, VUNO inc. announced that the Korean Ministry of Food and Drug Safety (KFDA) has designated the company’s artificial intelligence-based electrocardiogram (ECG) analysis software VUNO Med®-DeepECG™ as the ministry’s 16th Breakthrough Device. ...

ByVuno Inc.


NanoTemper Technologies teams up with PharmAI to help researchers spot game-changing drug candidates from millions of possibilities

NanoTemper Technologies teams up with PharmAI to help researchers spot game-changing drug candidates from millions of possibilities

Joachim Haupt, CEO of PharmAI. “Our software makes helpful predictions about drug candidates and reduces millions of possibilities to a manageable size. NanoTemper’s instruments and software are able to validate these predictions so that researchers can proceed directly with the ...

ByPharmAI GmbH

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT